Nanjing Vcare Selected for Nanjing Enterprise Technology Center Incubation Program

2025-01-06

　　Recently, the Nanjing Municipal Bureau of Industry and Information Technology released the Nanjing Enterprise Technology Center Incubation Program (2024)list, with Nanjing Vcare Pharmatech Co., Ltd. (Nanjing Vcare) successfully included. This achievement signifies official recognition of Nanjing Vcare's technological innovation and R&D capabilities, providing new momentum for the company's future development.

　　Leveraging this opportunity, Nanjing Vcare will further increase R&D investment and talent acquisition to enhance its technology center's capabilities, with the goal of progressing toward provincial and national-level enterprise technology center accreditation. Meanwhile, the company remains steadfast in its core philosophy of "The better Care, The better Medicines", focusing on comprehensive R&D and production services across the entire chemical drug value chain and product lifecycle. By accelerating technological innovation and commercialization of research outcomes, Nanjing Vcare will expedite the development of advanced technology platforms, strengthen its core competitiveness, and support sustainable corporate growth.

Prev

Nanjing Vcare Ranked Top 8 in "China's Top 20 Pharmaceutical CRO Enterprises" for Four Consecutive Years

Next

Nanjing Vcare Subsidiary Production Base Tianshu Pharmaceutical Completes On-Site Registration Inspection for Dapagliflozin API by NMPA